9th European Multidisciplinary Meeting on Urological Cancers (EMUC17) Multidisciplinary strategies in urogenital cancers Friday, 17 November 08.15-08.20 Welcome and Introduction Medical oncologist Thomas Powles, London (GB) - ESMO Radiation oncologist Peter Hoskin, Northwood (GB) - ESTRO Urologist Hein van Poppel, Leuven (BE) - EAU 08.20-10.05 Locally advanced and high risk prostate cancer Chairs: Radiologist - Raymond Oyen, Leuven (BE) Radiation oncologist - Thomas Wiegel, Ulm (DE) Urologist - Francesco Montorsi, Milan (IT) 08.20-09.00 MRI before biopsy for all men? YES vs NO Urologist - Hashim Ahmed, London (GB) Radiologist - Harriet Thoeny, Berne (CH) Radiologist - Olivier Rouvière, Lyon (FR) Urologist - Jochen Walz, Marseille (FR) Last judgement: Urologist - Nicolas Mottet, Saint-Étienne (FR) 09.00-09.15 Index lesion in prostate cancer: Myth or reality? Pathologist - Mark Rubin, New York (US) 09.15-09.20 Questions and answers 09.20-09.50 Will level 1 evidence influence our practice in focal therapy? YES Urologist - Mark Emberton, London (GB) vs NO Radiation oncologist - Alberto Bossi, Villejuif (FR) 09.50-10.05 Discussion Last judgement: Urologist - Arnauld Villers, Lille (FR) 10.05-10.50 The optimal primary treatment of prostate cancer: A focus on the ProtecT study Chairs: Radiologist - Raymond Oyen, Leuven (BE) Radiation oncologist - Thomas Wiegel, Ulm (DE) Urologist - Francesco Montorsi, Milan (IT) 10.05-10.15 ProtecT: What have we learnt? Radiation oncologist - Freddie Hamdy, Oxford (GB)
10.15-10.25 Would modern staging change the results? Urologist - Silvan Boxler, Berne (CH) 10.25-10.35 The statistician point of view Biostatistician - Mahesh Parmar, London (GB) 10.35-10.50 Discussion 10.50-11.20 Coffee break and poster viewing 11.20-12.35 Immunotherapy in urological cancers Chairs: Medical oncologist - Gerhardt Attard, Surrey (GB) Urologist - Alexander Govorov, Moscow (RU) Pathologist - Rodolfo Montironi, Ancona (IT) 11.20-11.35 Biological basics of immune therapy Immunologist - Elfriede Nossner, Munich (DE) 11.35-11.50 Prostate cancer Medical oncologist - Charles Drake, Baltimore (US) 11.50-12.05 Bladder cancer Medical oncologist - Andrea Necchi, Milan (IT) 12.05-12.20 Kidney cancer Medical oncologist - Thomas Powles, London (GB) 12.20-12.35 Discussion 12.35-12.45 Summary of EPCCCM Urologist - Manfred Wirth, Dresden (DE) 12.45-14.00 Lunch break and poster viewing 13.00-14.00 Industry session 14.00-15.15 Educational session on testis cancer: Clinical case discussion Chairs: Clinical oncologist - Jan Oldenburg, Oslo (NO) Radiation oncologist - Peter Hoskin, Northwood (GB) Urologist - Fred Witjes, Nijmegen (NL) Pathologist - Michelangelo Fiorentino, Bologna (IT) 14.00-14.15 Management of stage 1 Urologist - Peter Albers, Düsseldorf (DE) 14.15-14.30 Management of metastatic disease Medical oncologist - Karim Fizazi, Villejuif (FR) 14.30-15.15 Case discussion Stage I seminoma Urologist - Peter Albers, Düsseldorf (DE)
Medonc view Radonc view Medical oncologist - Karim Fizazi, Villejuif (FR) Radiation oncologist - Gert De Meerleer, Leuven (BE) Case discussion Residual disease Urologist - Peter Albers, Düsseldorf (DE) Medical oncologist - Karim Fizazi, Villejuif (FR) Radiation oncologist - Gert De Meerleer, Leuven (BE) 15.15-15-30 Best of journal session: Radiotherapy Chairs: Radiation oncologist - Bradley Pieters, Amsterdam (NL) Radiation oncologist Ananya Choudhury, Machester (UK) 15.30-16.00 Coffee break and poster viewing 16.00-17.45 Educational session on bladder cancer: Clinical case discussion Chairs: Radiotherapist - Anne Kiltie, Oxford (GB) Urologist - George Thalmann, Berne (CH) Pathologist - Antonio Lopez-Beltran, Lisbon (PT) Medical oncologist - Maria De Santis, Coventry (GB) 16.00-16.20 Bladder preservation: How and for whom? Radiation oncologist - Nicholas James, Birmingham (GB) 16.20-16.35 Lymph node dissection: How high is enough? Urologist - Stephen Boorjian, Rochester (US) 16.35-16.50 Molecular sub-types and implications for prognosis and therapy Urologist - Roland Seiler, Berne (CH) 16.50-17.45 Case discussion Radiation oncologist - Nicholas James, Birmingham (GB) Urologist - Stephen Boorjian, Rochester (US) Urologist - Roland Seiler, Berne (CH) 17.45-18.45 Industry session Saturday, 18 November 08.15-08.30 Announcement 3 best unmoderated posters Chairs: Clinical oncologist - Jan Oldenburg, Oslo (NO) Urologist - Michiel Sedelaar, Nijmegen (NL) 08.30-10.15 Oligometastatic kidney cancer Chairs: Radiation oncologist - Vincent Khoo, London (GB) Urologist - Hein Van Poppel, Leuven (BE) Medical oncologist - Thomas Powles, London (GB) Pathologist - Ferran Algaba, Barcelona (ES) 08.30-08.45 The optimal timing of cytoreductive nephrectomy
Urologist - Axel Bex, Amsterdam (NL) 08.45-09.00 Expanding knowledge of adjuvant therapy Urologist - Karim Bensalah, Rennes (FR) 09.00-09.15 Potential biomarkers for decision making Urological researcher - Kerstin Junker, Homburg (DE) 09.15-09.25 Can local ablation delay the use of systemic therapy for oligometastasis - Radiation therapy Radiation oncologist - Piet Ost, Ghent (BE) 09.25-10.15 Case discussion Urologist - Umberto Capitanio, Milan (IT) 10.15-10.45 Coffee break and poster viewing 10.45-11.25 Oral presentations of the 6 best abstracts Chairs: Medical oncologist - Susanne Osanto, Leiden (NL) Urologist - Hein Van Poppel, Leuven (BE) Radiation therapist - Barbara Jereczek-Fossa, Milan (IT) 11.25-11.45 Highlights of APCCC2017 Medical oncologist - Silke Gillessen, St. Gallen (CH) 11.45-12.15 Is there a shift for selection criteria and definition of reclassification for prostate cancer on active surveillance? Introduction: Pathologist - Rodolfo Montironi, Ancona (IT) Pathologist - Jonathan I. Epstein, Baltimore (US) 12.15-12.45 Stand-alone session on recent updates/novelties 12.45-14.00 Lunch break and poster viewing 13.00-14.00 Industry session 14.00-16.05 Management of loco/regional recurrences (prostate/penile cancer) Chairs: Medical oncologist - Silke Gillessen, St. Gallen (CH) Urologist - Georg Salomon, Hamburg (DE) Radiation therapist - Cesare Cozzarini, Milan (IT) 14.00-14.15 MRI/whole body MRI Radiologist - Frédéric Lecouvet, Brussels (BE) 14.15-14.35 Use of PET/CT Nuclear medicine - Stefano Fanti, Bologna (IT) 14.35-14.45 Salvage surgery after radiotherapy Urologist - Steven Joniau, Leuven (BE) 14.45-15.00 Salvage treatment after radical prostatectomy Radiation oncologist - Alberto Bossi, Villejuif (FR)
15.00-15.15 Management of local recurrences in penile cancer Urologist - Chris Protzel, Rostock (DE) 15.15-16.05 Case discussion Urologist - Gianluca Giannarini, Udine (IT) 16.05-16.35 Coffee break and poster viewing 16.35-16.50 Best of journals: Surgery Chairs: Urologist - Maurizio Brausi, Modena (IT) Urologist - Jochen Walz, Marseille (FR) 16.50-17.45 Educational session: Challenging cases in the management of Upper urinary tract TCC Chairs : Urologist - Evanguelos Xylinas, Paris (FR) Urologist - Joan Palou, Barcelona (ES) Clinical case discussion (including peri-operative chemo, imaging, pathologist, biopsy) Clinical Oncologist - Ananya Choudhury, Machester (UK) Urologist - Morgan Roupret, Paris (FR) Radiologist - Raymond Oyen, Leuven (BE) Pathologist - Sara Falzarano, Cleveland (US) 17.45-18.45 Industry session Sunday, 19 November 08.30-08.45 Announcement 3 best unmoderated posters Chairs: Clinical oncologist - Jan Oldenburg, Oslo (NO) Urologist - Igle-Jan de Jong, Groningen (NL) 08.45-09.00 Best of journals: Medical oncology Chairs: Medical oncologist - Cora Sternberg, Rome (IT) Medical oncologist - Andrea Necchi, Milan (IT) 09.00-09.15 Drug repurposing opportunities in uro-oncology Chairs: Medical oncologist - Cora Sternberg, Rome (IT) Urologist - Hein van Poppel, Leuven (BE) Dr. Director Anticancer fund - Gauthier Bouche, Strombeek-Bever (BE) 09.15-11.00 Evolving concepts in metastatic prostate cancer Chairs: Medical oncologist - Cora Sternberg, Rome (IT) Urologist - Jeffrey Karnes, New York (US) Radiation therapist - David Dearnaley, Sutton (GB) 09.15-09.30 How should we treat our metastatic castrate sensitive patients? Radiation oncologist - Nicholas James, Birmingham (GB) 09.30-09.45 Monitoring patients with metastatic disease Radiologist - Anwar Padhani, Northwood (GB)
09.45-10.00 Treatment of the primary in metastatic patients Urologist - Markus Graefen, Hamburg (DE) 10.00-10.15 Molecular radiotherapy Radiologist - Uwe Haberkorn, Heidelberg (DE) 10.15-11.00 Case discussion Urologist - Simon Brewster, Oxford (GB) 11.00-11.30 European Commission lecture Director General for Health and Food Safety - Xavier Prats Monné, Barcelona (ES) 11.30-12.20 Take home messages 11.30-11.40 Radiologist - Raymond Oyen, Leuven (BE) 11.40-11.50 Urologist - Igle-Jan de Jong, Groningen (NL) 11.50-12.00 Clinical oncologist - Jan Oldenburg, Oslo (NO) 12.00-12.10 Radiation oncologist - Bradley Pieters, Amsterdam (NL) 12.10-12.20 Pathologist - Rodolfo Montironi, Ancona (IT) 12.20-12.30 Closing remarks Clinical oncologist Radiation oncologist Urologist Jan Oldenburg, Oslo (NO) - ESMO Peter Hoskin, Northwood (GB) - ESTRO Hein van Poppel, Leuven (BE) - EAU